share_log

Avenue Therapeutics | EFFECT: Others

Avenue Therapeutics | EFFECT:其他

美股sec公告 ·  02/02 06:05
Moomoo AI 已提取核心訊息
Avenue Therapeutics, Inc. has announced the effectiveness of a Form S-3 filing with the United States Securities and Exchange Commission (SEC) as of February 1, 2024, at 5:00 P.M. The SEC's notice of effectiveness indicates that the company's registration statement has been accepted, allowing Avenue Therapeutics to issue securities as detailed in the filing under file number 333-276671.
Avenue Therapeutics, Inc. has announced the effectiveness of a Form S-3 filing with the United States Securities and Exchange Commission (SEC) as of February 1, 2024, at 5:00 P.M. The SEC's notice of effectiveness indicates that the company's registration statement has been accepted, allowing Avenue Therapeutics to issue securities as detailed in the filing under file number 333-276671.
Avenue Therapeutics, Inc.已於2024年2月1日下午5點宣佈自2024年2月1日下午5點起向美國證券交易委員會(SEC)提交的S-3表格生效。美國證券交易委員會的生效通知表明該公司的註冊聲明已被接受,允許Avenue Therapeutics發行文件中詳述的證券,文件編號爲333-276671。
Avenue Therapeutics, Inc.已於2024年2月1日下午5點宣佈自2024年2月1日下午5點起向美國證券交易委員會(SEC)提交的S-3表格生效。美國證券交易委員會的生效通知表明該公司的註冊聲明已被接受,允許Avenue Therapeutics發行文件中詳述的證券,文件編號爲333-276671。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息